Daisho Microline Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Daisho Microline Holdings has a total shareholder equity of HK$93.8M and total debt of HK$0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are HK$125.1M and HK$31.3M respectively.

Belangrijke informatie

Verhouding schuld/eigen vermogen

HK$0

Schuld

Rente dekkingsratio	n/a
Contant	HK$40.50m
Aandelen	HK$93.81m
Totaal verplichtingen	HK$31.30m
Totaal activa	HK$125.11m

Recente financiële gezondheidsupdates

Recent updates

Daisho Microline Holdings Limited's (HKG:567) 27% Price Boost Is Out Of Tune With Revenues

Oct 02

Revenues Not Telling The Story For Daisho Microline Holdings Limited (HKG:567) After Shares Rise 38%

Jul 01

Calculating The Fair Value Of Daisho Microline Holdings Limited (HKG:567)

Nov 29

Little Excitement Around Daisho Microline Holdings Limited's (HKG:567) Earnings As Shares Take 26% Pounding

Jul 13

Does Daisho Microline Holdings (HKG:567) Have A Healthy Balance Sheet?

Jul 07

Is Daisho Microline Holdings (HKG:567) A Risky Investment?

Mar 15

Daisho Microline Holdings (HKG:567) Is Making Moderate Use Of Debt

Nov 30

Analyse van de financiële positie

Kortlopende schulden: 567's short term assets (HK$78.2M) exceed its short term liabilities (HK$31.3M).

Langlopende schulden: 567's short term assets (HK$78.2M) exceed its long term liabilities (HK$14.0K).

Schuld/ eigen vermogen geschiedenis en analyse

Schuldniveau: 567 is debt free.

Schuld verminderen: 567 has no debt compared to 5 years ago when its debt to equity ratio was 75%.

Balans

Analyse van de cashflow

Voor bedrijven die in het verleden gemiddeld verliesgevend zijn geweest, beoordelen we of ze ten minste 1 jaar kasstroom hebben.

Stabiele cash runway: 567 has sufficient cash runway for more than 3 years based on its current free cash flow.

Voorspelling contante baan: 567 has sufficient cash runway for 1.5 years if free cash flow continues to grow at historical rates of 43.8% each year.

Daisho Microline Holdings Balans Gezondheid

Financiële gezondheid criteriumcontroles 6/6

Belangrijke informatie

Recente financiële gezondheidsupdates

Does Daisho Microline Holdings (HKG:567) Have A Healthy Balance Sheet?

Is Daisho Microline Holdings (HKG:567) A Risky Investment?

Daisho Microline Holdings (HKG:567) Is Making Moderate Use Of Debt

Recent updates

Daisho Microline Holdings Limited's (HKG:567) 27% Price Boost Is Out Of Tune With Revenues

Daisho Microline Holdings Limited Announces Board and Committee Changes

Full year 2024 earnings released: HK$0.007 loss per share (vs HK$0.016 loss in FY 2023)

Daisho Microline Holdings Limited, Annual General Meeting, Sep 20, 2024

Revenues Not Telling The Story For Daisho Microline Holdings Limited (HKG:567) After Shares Rise 38%

Full year 2024 earnings released: HK$0.007 loss per share (vs HK$0.016 loss in FY 2023)

New minor risk - Financial data availability

Daisho Microline Holdings Limited to Report Fiscal Year 2024 Results on Jun 25, 2024

Insufficient new directors

Daisho Microline Holdings Limited Announces Management Changes

New minor risk - Share price stability

Calculating The Fair Value Of Daisho Microline Holdings Limited (HKG:567)

First half 2024 earnings released: HK$0.003 loss per share (vs HK$0.013 loss in 1H 2023)

Daisho Microline Holdings Limited to Report First Half, 2024 Results on Nov 24, 2023

Daisho Microline Holdings Limited, Annual General Meeting, Sep 22, 2023

Little Excitement Around Daisho Microline Holdings Limited's (HKG:567) Earnings As Shares Take 26% Pounding

New major risk - Revenue and earnings growth

Full year 2023 earnings released: HK$0.016 loss per share (vs HK$0.026 loss in FY 2022)

Daisho Microline Holdings Limited to Report Fiscal Year 2023 Results on Jun 27, 2023

New minor risk - Financial data availability

First half 2023 earnings released: HK$0.012 loss per share (vs HK$0.019 loss in 1H 2022)

Daisho Microline Holdings Limited to Report First Half, 2023 Results on Nov 25, 2022

Full year 2022 earnings released: HK$0.026 loss per share (vs HK$0.058 loss in FY 2021)

Daisho Microline Holdings Limited, Annual General Meeting, Sep 23, 2022

Full year 2022 earnings released: HK$0.026 loss per share (vs HK$0.058 loss in FY 2021)

Daisho Microline Holdings Limited to Report Fiscal Year 2022 Results on Jun 24, 2022

Insider recently bought HK$24m worth of stock

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Insider recently sold HK$2.9m worth of stock

Does Daisho Microline Holdings (HKG:567) Have A Healthy Balance Sheet?

Full year 2021 earnings released: HK$0.058 loss per share (vs HK$0.15 loss in FY 2020)

Daisho Microline Holdings Limited Provides Unaudited Consolidated Earnings Guidance for the Year Ended March 31, 2021

Daisho Microline Holdings Limited has completed a Follow-on Equity Offering in the amount of HKD 13.1328 million.

Is Daisho Microline Holdings (HKG:567) A Risky Investment?

New 90-day high: HK$0.22

Daisho Microline Holdings (HKG:567) Is Making Moderate Use Of Debt

First half 2021 earnings released: HK$0.048 loss per share

Daisho Microline Holdings Limited to Report First Half, 2021 Results on Nov 27, 2020

Daisho Microline Holdings Limited Announces Board Changes

Daisho Microline Holdings Limited (SEHK:567) agree to acquire 2.02% stake in Pine Care Group Limited (SEHK:1989) from Tang Yiu Sing for HKD 29.9 million

Daisho Microline Holdings Limited has completed a Follow-on Equity Offering in the amount of HKD 18.2016 million.

Daisho Microline Holdings Limited Announces Change in Head Office and Principal Place of Business in Hong Kong

Analyse van de financiële positie

Schuld/ eigen vermogen geschiedenis en analyse

Balans

Analyse van de cashflow

Ontdek gezonde bedrijven